SEC Filing Analysis: SANGAMO THERAPEUTICS, INC (SGMO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer at Sangamo Therapeutics conducted a mandatory, non-discretionary sale of shares to cover tax liabilities arising from the vesting of Restricted Stock Units (RSUs).
• Market Impact: The transaction is too small relative to the company's market capitalization and is non-discretionary, so no market impact is expected.

Company Information

Field	Value
Company	SANGAMO THERAPEUTICS, INC
Ticker Symbol	SGMO
CIK	0001001233
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Willoughby Scott B.
CIK	0001877368
Title/Position	SVP, CHIEF LEGAL OFFICER, SECY
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-22
Transaction Code	F (Payment of tax liability by withholding securities)
Security Type	Common Stock
Shares Involved	44,122
Price Per Share	$0.66
Total Value	$29,120.52
Shares Owned After	704,121
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$29,120.52
% of Market Cap	0.015%
Shares Transacted	44,122
% of Shares Outstanding	0.015%
Post-Transaction Ownership	704,121 shares (0.23% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Sangamo Therapeutics is a small-cap company with a market capitalization of approximately $190 million. The transaction value of ~$29k is immaterial in this context.
• Ownership Concentration: The insider, Scott Willoughby, continues to hold 704,121 shares, representing approximately 0.23% of the total shares outstanding. This sale represents about 5.9% of his prior holdings, but its mandatory nature reduces its significance.
• Dilution Impact: This transaction is a sale of existing shares to the issuer for tax purposes, not an issuance of new shares, so it has no dilutive impact.
• Transaction Significance: The transaction is rated 'Low' significance. Both its value as a percentage of market cap (0.015%) and shares as a percentage of outstanding shares (0.015%) are well below the thresholds for moderate or high significance. The 'F' transaction code confirms it is a routine, non-discretionary event.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a mandatory sale to cover taxes, not a discretionary trade reflecting the insider's sentiment about the company's future prospects. The market typically ignores such transactions.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction is small and does not represent an open-market trade that would affect trading volume.
• Sentiment Indicator: Neutral. This filing provides no new information regarding insider confidence.

Investment Insights

Positive Market Indicators

• The insider maintains a substantial holding of over 700,000 shares after the transaction, indicating continued alignment with shareholder interests.

Risk Factors

• No new risk factors are indicated by this filing.

Key Takeaways

1. The sale by the SVP & Chief Legal Officer was not a discretionary market sale but a required withholding to cover taxes on vested RSUs.
2. The transaction's value and share count are insignificant relative to the company's market cap and shares outstanding.
3. The filing should be considered routine and does not signal a change in the insider's outlook on the company.

Additional Context

Transaction Notes

• Special Circumstances: The filing's footnote explicitly states the shares were surrendered "solely for mandatory tax withholding purposes" and that the transaction "does not represent a discretionary trade by the Reporting Person."
• Market Environment: The transaction is a routine corporate action related to equity compensation and is independent of broader market conditions.